To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Effect of Topical Application of NSAID Lateral to the Incision on Postoperative Pain Following UKA

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
March 2025

Effect of Topical Application of NSAID Lateral to the Incision on Postoperative Pain Following UKA

Vol: 307| Issue: 3| Number:15| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Effect of Topical Application of an NSAID Lateral to the Incision on Postoperative Pain Following Unicompartmental Knee Arthroplasty: A Double-Blind Randomized Controlled Trial.

Orthop Surg . 2024 Jul;16(7):1555-1561.

Contributing Authors:
C Li L Li Y Li D Liu K Han R Zhu Y Zhao Q Lu

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Ninety-eight patients undergoing unicompartmental knee arthroplasty (UKA) were randomized to receive either topical NSAIDs applied lateral to the incision postoperatively (n=48) or a placebo (n=50). The primary outcomes of interest were opioid consumption and the visual analogue scale (VAS) score for pain at 12, 24, 36, 48, and 72 hours postoperatively. Secondary outcomes included the American Kne...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue